LISSSD 2025 christina dold
Moderna, USA, United States
- This delegate is presenting an abstract at this event.
Presentations this author is a contributor to:
Optimizing formulation of the Group A Streptococcus mRNA vaccine candidate Combo#5 (#192)
5:30 PM
Brody Pullinger
Poster Session 1
The Combo#5 mRNA-LNP Group A Streptococcus vaccine generates robust memory CD4+ and CD8+ effector T cells in mice. (118586)
11:27 AM
Rhiannon A Bolton
Plenary 11 - Lancefield Time Machine - The Shape of Things to Come